Can GPR4 Be a Potential Therapeutic Target for COVID-19?
Medicine
[키워드] acute respiratory syndrome
asymptomatic infection
Can
cause
caused
Cell
clinical manifestation
coronavirus
coronavirus disease 19
COVID-19
death
Diffuse alveolar damage
edema
Endothelial cell
expressed
G protein-coupled receptor
global pandemic
GPR4
hyper-inflammatory response
Inflammation
inflammatory cell infiltration
inflammatory conditions
Injury
Interaction
leukocyte infiltration
lung
mild respiratory
mitigate
other organ
other organs
pathological findings
pathophysiology
Potential
potential therapeutic target
pro-inflammatory
Pulmonary edema
regulate
Respiratory failure
SARS-CoV-2
SARS-COV-2 infection
severe pneumonia
target
Thromboembolism
tissue
tissue injury
Treatment
Vascular
vascular endothelial cell
vascular permeability
vessel
with COVID-19
[DOI] 10.3389/fmed.2020.626796 PMC 바로가기 [Article Type] Medicine
[DOI] 10.3389/fmed.2020.626796 PMC 바로가기 [Article Type] Medicine